首页> 外文OA文献 >Synthesis, characterization and antitumor activity of copper(II) complexes, CuL2 HL1-3=N,N-Diethyl-N'-(R-Benzoyl)Thiourea (R=H, o-Cl and p-NO2)
【2h】

Synthesis, characterization and antitumor activity of copper(II) complexes, CuL2 HL1-3=N,N-Diethyl-N'-(R-Benzoyl)Thiourea (R=H, o-Cl and p-NO2)

机译:铜(II)配合物CuL2 HL1-3 = N,N-二乙基-N'-(R-苄基)硫脲(R = H,o-Cl和p-NO2)的合成,表征和抗肿瘤活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The copper (II) complexes (CuL2) were prepared by reaction of Cu(CH3COO)2 with the correspondingderivatives of acylthioureas in a Cu:HL molar ratio of 1:2. Acylthiourea ligands, N,N-diethyl-N’ (Rbenzoyl)thiourea (HLj’3) JR=H, o-C1 and p-NO2] were synthesized in high yield (78-83%) and characterizedby elemental analysis, infrared spectroscopy, H and 13C NMR spectroscopy. The complexes CuL2 werecharacterized by elemental analysis, IR, FAB(+)-MS, magnetic susceptibility measurements, EPR and cyclicvoltammetry. The crystal structure of the complex Cu(L2)z shows a nearly square-planar geometry with twodeprotonated ligands (L) coordinated to Cun through the oxygen and sulfur atoms in a cis arrangement. Theantitumor activity of the copper(II) complexes with acylthiourea ligands was evaluated in vitro against themouse mammary adenocarcinoma TA3 cell line. These complexes exhibited much higher cytotoxic activity(ICs0 values in the range of 3.9-6.9 tM) than their corresponding ligands (40-240 tM), which indicates thatthe coordination of the chelate ligands around the CuII enhances the antitumor activity and, furthermore, thisresult confirmed that the participation of the nitro and chloro substituent groups in the complex activities isslightly relevant. The high accumulation of the complexes Cu(L)2 and Cu(L3)2 in TA3 tumor cells and themuch faster binding to cellular DNA than Cu(L1)2 are consistent with the in vitro cytotoxic activities foundfor these copper complexes.
机译:通过使Cu(CH3COO)2与相应的酰基硫脲衍生物以Cu:HL摩尔比为1:2反应制备铜(II)配合物(CuL2)。酰基硫脲配体N,N-二乙基-N'(R苯甲酰基)硫脲(HLj'3)JR = H,o-C1和p-NO2]的合成产率高(78-83%),并通过元素分析,红外光谱法进行了表征,1 H和13 C NMR光谱。通过元素分析,IR,FAB(+)-MS,磁化率测量,EPR和循环伏安法表征了CuL2的配合物。复杂的Cu(L2)z的晶体结构显示出几乎为正方形的几何结构,带有两个去质子化的配体(L)通过氧和硫原子以顺式排列方式与Cun配位。在体外评估了铜(II)与酰基硫脲配体的抗肿瘤活性对小鼠乳腺腺癌TA3细胞系的抑制作用。这些复合物比其相应的配体(40-240 tM)表现出更高的细胞毒性活性(ICs0值在3.9-6.9 tM范围内),这表明CuII周围的螯合配体的配位增强了抗肿瘤活性,而且,这一结果证实了硝基和氯取代基团参与复杂活性的相关性很小。络合物Cu(L)2和Cu(L3)2在TA3肿瘤细胞中的高度积累以及比Cu(L1)2更快的与细胞DNA的结合与这些铜络合物的体外细胞毒活性一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号